Caprolactam Chemicals Ltd. (BSE: 507486) is a Mahad, Maharashtra-based company in the Pharmaceutical Intermediates industry. With a market capitalisation of ₹0 Cr, it ranks #5,217 by market cap among the 6,197 Indian listed companies on FinBizNet, and #4 of 4 in Pharmaceutical Intermediates. At ₹46.01 (as of 16 Nov 2026), the share price is 43.2% below its 52-week high of ₹81.00 and 24.0% above its 52-week low of ₹37.10. The share price is down 2.0% over one year and up 1.2% over three months.
| Current Price | ₹46.01 |
|---|---|
| Market Cap | ₹0 Cr |
| BSE Code | 507486 |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Pharmaceutical Intermediates |
| P/E Ratio | 12 |
| Return on Equity | 30.87% |
| Return on Assets | 11.39% |
| 52-Week Range | ₹37.10 – ₹81.00 |
| 1-Year Price Change | -2.0% |
| 3-Month Price Change | +1.2% |
| Beta (1Y) | 1.05 |
| Headquarters | Mahad, Maharashtra |
| Website | www.caprolactam.co.in |
| Revenue | ₹0 Cr |
|---|---|
| Net Profit | ₹-1 Cr |
| Net Margin | -210.6% |
| EPS (Basic) | ₹2.15 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Caprolactam Chemicals Ltd. reported revenue of ₹0 Cr in Q1 FY27, down 81.6% from ₹3 Cr in Q1 FY26 and down 84.7% from ₹3 Cr in Q4 FY26. It posted a net loss of ₹1 Cr for the quarter, against a net profit of ₹0 Cr in Q1 FY26. Across the 6 quarters from Q4 FY25 to Q1 FY27, quarterly revenue ranged from ₹0 Cr (Q1 FY27) to ₹3 Cr (Q4 FY26). The company reported a net loss in 2 of these 6 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q1 FY27 | ₹0 Cr | −₹1 Cr | −210.6% |
| Q4 FY26 | ₹3 Cr | ₹1 Cr | 27.4% |
| Q3 FY26 | ₹3 Cr | ₹0 Cr | 17.2% |
| Q2 FY26 | ₹2 Cr | ₹0 Cr | 5.5% |
| Q1 FY26 | ₹3 Cr | ₹0 Cr | 14.1% |
| Q4 FY25 | ₹2 Cr | −₹0 Cr | −28.0% |
Standalone figures (₹ crore, XBRL filings).
Delivery averaged 99.6% of traded volume across 12 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Caprolactam Chemicals Limited engages in the manufacture and sale of chemicals in India. It also provides job work services. The company was formerly known as Vamotiwala Chemicals Industries Limited and changed its name to Caprolactam Chemicals Limited. Caprolactam Chemicals Limited was incorporated in 1988 and is based in Mahad, India.
1. Manufacturing-This segment engages in the contract manufacture of chemicals and intermediates in India. It offers products for flavours and fragrance, aroma, pharma, and agro chemical industries.
1. Manufacturing-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| DCM Shriram Fine Chemicals Limited | ₹236 Cr | n/m | -1.67% | ₹90 Cr | — |
| Samrat Pharmachem Ltd. | ₹79 Cr | n/m | -4.73% | ₹80 Cr | -7.0% |
| Eiko Lifesciences Ltd | ₹69 Cr | 15.3 | 8.40% | — | -13.1% |
| Caprolactam Chemicals Ltd. | ₹0 Cr | 12 | 30.87% | ₹0 Cr | -2.0% |
Listed by market capitalisation. Ratios are shown for context only.
Caprolactam Chemicals Ltd. is trading at ₹46.01, with a market capitalisation of ₹0 Cr.
Caprolactam Chemicals Ltd. operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Pharmaceutical Intermediates).
Caprolactam Chemicals Ltd. has a P/E of 12 and a return on equity of 30.87%.
Caprolactam Chemicals Ltd. is listed on the BSE under the scrip code 507486.
Caprolactam Chemicals Ltd.'s share price is down 2.0% over one year and up 1.2% over three months. Its 52-week range is ₹37.10 to ₹81.00.
In Q1 FY27, Caprolactam Chemicals Ltd. reported revenue of ₹0 Cr and net profit of ₹-1 Cr, with basic EPS of ₹2.15 (standalone, parsed from the company's exchange filing).
Caprolactam Chemicals Ltd. reported revenue of ₹0 Cr in Q1 FY27, down 81.6% from ₹3 Cr in Q1 FY26 and down 84.7% from ₹3 Cr in Q4 FY26.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.